VANCOUVER, BC / ACCESS Newswire / February 27, 2026 / Empress Royalty Corp. (TSXV:EMPR)(OTCQX:EMPYF) ("Empress" or the "Company") is pleased to announce its audited financial and operating results for ...

If you are wondering whether Celldex Therapeutics at around US$30 a share represents fair value or a potential opportunity, this article will walk you through what the current price might be implying.

Allspring Special Large Cap Value Fund reported a 16.79% return for 2025, beating its benchmark. Read the full analysis for more details.

GSTAT held that although profiteering of ₹1.70 crore was computed, the developer had passed on ₹2.02 crore to home-buyers. With compliance under Section 171 CGST established, no penalty was imposed, ...